Targeting the peptide deformylase of Mycobacterium tuberculosis leads to drug discovery

Letters in Drug Design and Discovery

Volumn 6, Issue 7, 2009, Pages 487-493

  Singh, Vijai ^a   Somvanshi, Pallavi ^a  

^a Bioinformatics Centre   (India)

Author keywords

Docking; Drugs; Mycobacterium tuberculosis; Peptide deformylase; Phylogeny

Indexed keywords

ACTINONIN; ANTIMYCOBACTERIAL AGENT; BBS 02; BBS 52; BBS 54; BBS 88; N (1 TERT BUTYL 2 DIMETHYLAMINO 2 OXOETHYL) 2 (N FORMYL N HYDROXYAMINOMETHYL)HEXANAMIDE; PEPTIDE DEFORMYLASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DRUG DESIGN; DRUG TARGETING; ENZYME ACTIVITY; ENZYME BINDING; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS H37RV; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRAIN IMPROVEMENT; THREE DIMENSIONAL IMAGING;

EID: 69449106017     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018009789108286     Document Type: Article

References (21)

1. Dye, C.; Watt, C. J.; Bleed, D. M.; Hosseini, S. M.; Raviglione, M. C. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA, 2005, 293, 2767-2775.
2. Dye, C. Global epidemiology of tuberculosis. Lancet, 2006, 367, 938-940.
3. Kremer, L. S.; Besra, G. S. Current status and future development of antitubercular chemotherapy. Expert Opin. Investig. Drugs, 2002, 1, 1033-1049. (Pubitemid 34905752)
4. Chikhi, A.; Bensegueni, A.; Boulahrouf, A.; Bencharif, M. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs. In Silico Biol., 2006, 6, 0043. (Pubitemid 44857642)
5. Apfel, C.; Banner, D. W.; Bur, D.; Dietz, M.; Hirata, T.; Hubschwerlen, C.; Locher, H.; Page, M. G.; Pirson, W.; Rosse, G.; Specklin J. L. Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents. J. Med. Chem., 2000, 43, 2324-2331. (Pubitemid 30431930)
6. Singh, V.; Somvanshi, P. Inhibition of oligomerization of aerolysin from Aeromonas hydrophila: homology modeling and docking approach for exploration of hemorrhagic septicemia. Lett. Drug Des. Discov., 2009, 6(3), 215-223.
7. Singh, V.; Somvanshi, P.; Rathore, G.; Kapoor, D.; Mishra, B.N. Gene cloning, expression and homology modelling of hemolysin gene from Aeromonas hydrophila. Protein Expr. Purif., 2009, 65, 1-7.
8. Singh, V.; Somvanshi, P. Homology modeling of 3-oxoacyl-acyl carrier protein synthase II (KAS II) from Mycobacterium tuberculosis H37Rv and molecular docking for exploration of drugs. J. Mol. Mod., 2009, 15(5), 453-460.
9. Chen, D.Z.; Patel, D.V.; Hackbarth, C.J; Wang, W.; Dreyer, G.; Young, D.C.; Margolis, P.S.; Wu, C.; Ni, Z-J.; Trias, J.; White, R.J.; Yuan, Z. "Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor," Antimicrob. Agents Chemother., 2000, 45(2), 563-570.
10. Meinnel, T.; Blanquet, S.; Dardel, F. A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase. J. Mol. Biol., 1996, 262, 375-386. (Pubitemid 126353206)
11. Meinnel, T.C.; Lazennec, S.; Villoing; Blanquet S. Structure function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion. J. Mol. Biol., 1997, 267, 749-761.
12. Yuan, Z.; Trias J.; White, R. J. Deformylase as a novel antibacterial target. Drug Discov. Today, 2001, 6, 954-961.
13. Altschul, S. F.; Thomas L. M.; Alejandro A. S.; Jinghui Z.; Zheng Z.; Miller W.; Lipman, D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res., 1997, 25, 3389-3402.
14. Sali A.; Blundell T.L. Comparative protein modeling by satisfaction of spatial restrains, J. Mol. Biol., 1993, 234, 779-815. (Pubitemid 24007801)
15. Delano, W.L.; Palo Alto, C.A. The PYMOL molecular graphics system. Delano Scientific: Palo Alto, CA, USA, 2002.
16. Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structure, J. Appl. Crystallogr., 1993, 26, 283-291.
17. Morris, G.M.; Goodsell, D.S.; Halliday R.S.; Huey, R.; Hart, W.E., Belew, R.K., Olson, A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comp. Chem., 1998, 19, 1639-1662.
18. Thompson, J. D.; Gibson, T. J.; Plewniak, F.; Jeanmougin, F.; Higgins, D. G. The CLUSTALX windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res., 1997, 25, 4876-4882.
19. Tamura, K.; Dudley, J.; Nei, M.; Kumar, S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol., 2007, 24, 1596-1599. (Pubitemid 47236692)
20. Clements, J.M.; Beckett, R.P.; Brown, A.; Catlin, G.; Lobell, M.; Palan, S.; Thomas, W.; Whittaker, M.; Wood., S.; Salama, S.; Baker, P.J.; Rodgers, H.F.; Barynin, V.; Rice, D.W. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor, Antimicrob. Agents Chemother., 2001, 45(2), 563-570. (Pubitemid 32105294)
21. Fritsche, T.R.; Sader, H.S.; Cleeland, R.; Jones, R.N. Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance," Antimicrob. Agents Chemother., 2005, 49(4), 1468-1476.